Sertoli-Leydig tumor and DICER1 gene mutation: A case series and literature review

被引:0
|
作者
Durden, Andrew A. [1 ,3 ]
Cass, Gemma K. [1 ]
Newton, Claire [1 ,2 ]
机构
[1] Univ Hosp Bristol & Weston NHS Trust, St Michaels Hosp, Dept Gynaecol Oncol, Bristol, England
[2] Univ Bristol, Bristol, England
[3] St Michaels Hosp, Southwell St, Bristol BS2 8EG, England
关键词
DICER1; pre-natal genetics; Sertoli-Leydig; surveillance; CELL TUMORS; HOTSPOT MUTATIONS; CLINICOPATHOLOGICAL ANALYSIS; OVARIAN; MICRORNAS; CANCER;
D O I
10.1111/jog.15939
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Sertoli-Leydig cell tumors (SLCTs) are rare neoplasms occurring in young women with 60% associated with DICER1 mutations. This is only the second published case series of patients with SLCTs with associated DICER1 gene alterations. DICER1 syndrome is a rare inherited tumor-susceptibility syndrome affecting organs such as the ovaries. We use this case series to inform readers on this increasingly important condition in gynecology. Methods and Results: We present three young females presenting with secondary amenorrhoea, hirsutism, acne and in one case tonic-clonic seizures. All cases had high testosterone levels and an adnexal mass on ultrasound. Following surgical removal, pathology confirmed SLCTs and genetic testing followed. All three patients had DICER1 syndrome with two patients subsequently found to be related. Discussion: The prevalence of DICER1 syndrome in the population is estimated to be 1 in 10 000 with a spectrum of sex cord stromal tumors affecting young women. The associated pathological classifications and management. This paper describes the DICER1 gene and the associated tumor predisposition syndrome alongside a surveillance protocol for use in clinical practice. It promotes discussion over the importance of early clinical genetics involvement in sex-cord stromal tumors and the associated difficulties in counseling in a young patient population. Genetic testing and early detection are imperative for targeted surveillance of at-risk organs to be performed but despite this there is no international guidance. The cases highlight the psychological impact of tumors in young patients and provokes an ethical discussion over DICER1 gene's inclusion in preimplantation genetics. Conclusions: DICER1 syndrome is a rare but increasingly important condition in pediatric and adolescent gynecology with a paucity of published data and case reports. This makes international consensus on management and surveillance difficult.
引用
收藏
页码:1132 / 1140
页数:9
相关论文
共 50 条
  • [1] Sertoli-Leydig cell tumor with DICER1 mutation
    Jansen, Shae N.
    McCarty, Samantha L.
    Landrum, Lisa M.
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2024, 52
  • [2] DICER1 Mutation in Recurrent Ovarian Sertoli-Leydig Cell Tumor: A Case Report
    Liu, Shalon
    Pokoradi, Alida J.
    Soboleski, Donald
    Childs, Timothy
    Agrawal, Anita
    [J]. JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2023, 36 (02) : 107 - 111
  • [3] Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome A case report and literature review
    Zhang, Ying
    Ren, Meng
    Hong, Yazhen
    Zhong, Yanping
    Cong, Xiaofeng
    Chen, Chen
    Liu, Ziling
    Man, Yu
    Yang, Lei
    [J]. MEDICINE, 2020, 99 (27) : E20806
  • [4] The Case of Combination of Multinodular Goiter and Sertoli-Leydig Cell Ovarian Tumor Due to Mutation in DICER1 Gene
    Kolodkina, Anna
    Makretskaya, Nina
    Tiulpakov, Anatoly
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 490 - 491
  • [5] A CASE OF DICER1 SYNDROME WITH SERTOLI-LEYDIG CELL TUMOR AND INTRACRANIAL SARCOMA
    Nishimura, Katsuhiro
    Terui, Keita
    Takenouchi, Ayako
    Komatsu, Shugo
    Oita, Satoru
    Yoshizawa, Hiroko
    Fumita, Takashi
    Motoyoshi, Kiwamu
    Matsutani, Tomoo
    Hishiki, Tomoro
    [J]. PEDIATRIC BLOOD & CANCER, 2022, 69
  • [6] Mesenteric extraovarian Sertoli-Leydig cell tumor without DICER1 hotspot mutation: a case report
    Mitsumasa Osakabe
    Chie Sato
    Masamichi Suzuki
    Ryo Sugimoto
    Yasuko Fujita
    Noriyuki Uesugi
    Kazuyuki Ishida
    Hiroaki Itamochi
    Tsukasa Baba
    Tamotsu Sugai
    [J]. Diagnostic Pathology, 14
  • [7] Mesenteric extraovarian Sertoli-Leydig cell tumor without DICER1 hotspot mutation: a case report
    Osakabe, Mitsumasa
    Sato, Chie
    Suzuki, Masamichi
    Sugimoto, Ryo
    Fujita, Yasuko
    Uesugi, Noriyuki
    Ishida, Kazuyuki
    Itamochi, Hiroaki
    Baba, Tsukasa
    Sugai, Tamotsu
    [J]. DIAGNOSTIC PATHOLOGY, 2019, 14 (1)
  • [8] A family with Sertoli-Leydig cell tumour, multinodular goiter, and DICER1 mutation
    Haley, M.
    Bindal, P.
    McAuliffe, A.
    Vredenburgh, J.
    [J]. CURRENT ONCOLOGY, 2019, 26 (03) : 183 - 185
  • [9] Ovarian Sertoli-Leydig Cell Tumor, Multinodular Goiter, Cystic Nephromas and DICER1 Mutations: Case Report and Literature Review
    Ni, Yanglin
    Zhou, Xuan
    Wu, Ling
    Wu, Ping
    Liu, Ying
    Li, Yinnan
    Cai, Li
    Fu, Xueshu
    Zhang, Chunhua
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2021, 14 : 947 - 953
  • [10] Intronic Germline DICER1 Variants in Patients With Sertoli-Leydig Cell Tumor
    Fraire, Claudette R.
    Mallinger, Paige R.
    Hatton, Jessica N.
    Kim, Jung
    Dickens, David S.
    Argenta, Peter A.
    Milanovich, Samuel
    Hartshorne, Taylor
    Carey, David J.
    Haley, Jeremy S.
    Urban, Gretchen
    Lee, Jeon
    Hill, D. Ashley
    Stewart, Douglas R.
    Schultz, Kris Ann P.
    Chen, Kenneth S.
    [J]. JCO PRECISION ONCOLOGY, 2023, 7